
Management of common variable immunodeficiency by subcutaneous IgG self‐administration during pregnancy – a case report
Author(s) -
Marasco Carolina,
Venturelli Alberta,
Rao Luigia,
Vacca Angelo,
Carratù Maria Rosaria
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.692
Subject(s) - common variable immunodeficiency , medicine , pregnancy , adverse effect , immunology , antibody , fetus , pediatrics , intensive care medicine , genetics , biology
Key Clinical Message Patients with common variable immunodeficiency are prone to infections, and this poses a particular challenge during pregnancy, when the requirement for immunoglobulin (Ig) replacement therapy is even more demanding so as to achieve an effective protection also of the fetus. This case report highlights the benefits observed with subcutaneous IgG self‐administration in the management of common variable immunodeficiency ( CVID ) during pregnancy, in terms of efficacy and safety.